Medical Biology - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 9 of 9
  • Item
    No Preview Available
    Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
    Abdulla, HDD ; Alserihi, R ; Flensburg, C ; Abeysekera, W ; Luo, M-X ; Gray, DHD ; Liu, X ; Smyth, GKK ; Alexander, WSS ; Majewski, IJJ ; McCormack, MPP (ROCKEFELLER UNIV PRESS, 2023-03-15)
    Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. This autonomous thymic maintenance results in the development of self-renewing preleukemic stem cells (pre-LSCs) and subsequent leukemogenesis, both of which are profoundly inhibited by restoration of thymic competition or expression of the antiapoptotic factor BCL2. Genomic analyses revealed the presence of Notch1 mutations in pre-LSCs before subsequent loss of tumor suppressors promotes the transition to overt leukemogenesis. These studies demonstrate a critical role for impaired cell competition in the development of pre-LSCs in a transgenic mouse model of T cell acute lymphoblastic leukemia (T-ALL), implying that this process plays a role in the ontogeny of human T-ALL.
  • Item
    Thumbnail Image
    A non-canonical function of Ezh2 preserves immune homeostasis
    Vasanthakumar, A ; Xu, D ; Lun, ATL ; Kueh, AJ ; van Gisbergen, KPJM ; Iannarella, N ; Li, X ; Yu, L ; Wang, D ; Williams, BRG ; Lee, SCW ; Majewski, IJ ; Godfrey, DI ; Smyth, GK ; Alexander, WS ; Herold, MJ ; Kallies, A ; Nutt, SL ; Allan, RS (WILEY, 2017-04)
    Enhancer of zeste 2 (Ezh2) mainly methylates lysine 27 of histone-H3 (H3K27me3) as part of the polycomb repressive complex 2 (PRC2) together with Suz12 and Eed. However, Ezh2 can also modify non-histone substrates, although it is unclear whether this mechanism has a role during development. Here, we present evidence for a chromatin-independent role of Ezh2 during T-cell development and immune homeostasis. T-cell-specific depletion of Ezh2 induces a pronounced expansion of natural killer T (NKT) cells, although Ezh2-deficient T cells maintain normal levels of H3K27me3. In contrast, removal of Suz12 or Eed destabilizes canonical PRC2 function and ablates NKT cell development completely. We further show that Ezh2 directly methylates the NKT cell lineage defining transcription factor PLZF, leading to its ubiquitination and subsequent degradation. Sustained PLZF expression in Ezh2-deficient mice is associated with the expansion of a subset of NKT cells that cause immune perturbation. Taken together, we have identified a chromatin-independent function of Ezh2 that impacts on the development of the immune system.
  • Item
    Thumbnail Image
    Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids
    Michalak, EM ; Milevskiy, MJG ; Joyce, RM ; Dekkers, JF ; Jamieson, PR ; Pal, B ; Dawson, CA ; Hu, Y ; Orkin, SH ; Alexander, WS ; Lindeman, GJ ; Smyth, GK ; Visvader, JE ; Rawlins, E (PUBLIC LIBRARY SCIENCE, 2018-08)
    Distinct transcriptional states are maintained through organization of chromatin, resulting from the sum of numerous repressive and active histone modifications, into tightly packaged heterochromatin versus more accessible euchromatin. Polycomb repressive complex 2 (PRC2) is the main mammalian complex responsible for histone 3 lysine 27 trimethylation (H3K27me3) and is integral to chromatin organization. Using in vitro and in vivo studies, we show that deletion of Suz12, a core component of all PRC2 complexes, results in loss of H3K27me3 and H3K27 dimethylation (H3K27me2), completely blocks normal mammary gland development, and profoundly curtails progenitor activity in 3D organoid cultures. Through the application of mammary organoids to bypass the severe phenotype associated with Suz12 loss in vivo, we have explored gene expression and chromatin structure in wild-type and Suz12-deleted basal-derived organoids. Analysis of organoids led to the identification of lineage-specific changes in gene expression and chromatin structure, inferring cell type-specific PRC2-mediated gene silencing of the chromatin state. These expression changes were accompanied by cell cycle arrest but not lineage infidelity. Together, these data indicate that canonical PRC2 function is essential for development of the mammary gland through the repression of alternate transcription programs and maintenance of chromatin states.
  • Item
    Thumbnail Image
    Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity
    Majewski, IJ ; Blewitt, ME ; de Graaf, CA ; McManus, EJ ; Bahlo, M ; Hilton, AA ; Hyland, CD ; Smyth, GK ; Corbin, JE ; Metcalf, D ; Alexander, WS ; Hilton, DJ ; Goodell, MA (PUBLIC LIBRARY SCIENCE, 2008-04)
    Polycomb group proteins are transcriptional repressors that play a central role in the establishment and maintenance of gene expression patterns during development. Using mice with an N-ethyl-N-nitrosourea (ENU)-induced mutation in Suppressor of Zeste 12 (Suz12), a core component of Polycomb Repressive Complex 2 (PRC2), we show here that loss of Suz12 function enhances hematopoietic stem cell (HSC) activity. In addition to these effects on a wild-type genetic background, mutations in Suz12 are sufficient to ameliorate the stem cell defect and thrombocytopenia present in mice that lack the thrombopoietin receptor (c-Mpl). To investigate the molecular targets of the PRC2 complex in the HSC compartment, we examined changes in global patterns of gene expression in cells deficient in Suz12. We identified a distinct set of genes that are regulated by Suz12 in hematopoietic cells, including eight genes that appear to be highly responsive to PRC2 function within this compartment. These data suggest that PRC2 is required to maintain a specific gene expression pattern in hematopoiesis that is indispensable to normal stem cell function.
  • Item
    Thumbnail Image
    An Erg-driven transcriptional program controls B cell lymphopoiesis.
    Ng, AP ; Coughlan, HD ; Hediyeh-Zadeh, S ; Behrens, K ; Johanson, TM ; Low, MSY ; Bell, CC ; Gilan, O ; Chan, Y-C ; Kueh, AJ ; Boudier, T ; Feltham, R ; Gabrielyan, A ; DiRago, L ; Hyland, CD ; Ierino, H ; Mifsud, S ; Viney, E ; Willson, T ; Dawson, MA ; Allan, RS ; Herold, MJ ; Rogers, K ; Tarlinton, DM ; Smyth, GK ; Davis, MJ ; Nutt, SL ; Alexander, WS (Nature Research (part of Springer Nature), 2020-06-15)
    B lymphoid development is initiated by the differentiation of hematopoietic stem cells into lineage committed progenitors, ultimately generating mature B cells. This highly regulated process generates clonal immunological diversity via recombination of immunoglobulin V, D and J gene segments. While several transcription factors that control B cell development and V(D)J recombination have been defined, how these processes are initiated and coordinated into a precise regulatory network remains poorly understood. Here, we show that the transcription factor ETS Related Gene (Erg) is essential for early B lymphoid differentiation. Erg initiates a transcriptional network involving the B cell lineage defining genes, Ebf1 and Pax5, which directly promotes expression of key genes involved in V(D)J recombination and formation of the B cell receptor. Complementation of Erg deficiency with a productively rearranged immunoglobulin gene rescued B lineage development, demonstrating that Erg is an essential and stage-specific regulator of the gene regulatory network controlling B lymphopoiesis.
  • Item
    No Preview Available
    Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a
    Shields, BJ ; Jackson, JT ; Metcalf, D ; Shi, W ; Huang, Q ; Garnham, AL ; Glaser, SP ; Beck, D ; Pimanda, JE ; Bogue, CW ; Smyth, GK ; Alexander, WS ; McCormack, MP (COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, 2016-01-01)
    Unlike clustered HOX genes, the role of nonclustered homeobox gene family members in hematopoiesis and leukemogenesis has not been extensively studied. Here we found that the hematopoietically expressed homeobox gene Hhex is overexpressed in acute myeloid leukemia (AML) and is essential for the initiation and propagation of MLL-ENL-induced AML but dispensable for normal myelopoiesis, indicating a specific requirement for Hhex for leukemic growth. Loss of Hhex leads to expression of the Cdkn2a-encoded tumor suppressors p16(INK4a) and p19(ARF), which are required for growth arrest and myeloid differentiation following Hhex deletion. Mechanistically, we show that Hhex binds to the Cdkn2a locus and directly interacts with the Polycomb-repressive complex 2 (PRC2) to enable H3K27me3-mediated epigenetic repression. Thus, Hhex is a potential therapeutic target that is specifically required for AML stem cells to repress tumor suppressor pathways and enable continued self-renewal.
  • Item
    Thumbnail Image
    Haemopedia: An Expression Atlas of Murine Hematopoietic Cells
    De Graaf, CA ; Choi, J ; Baldwin, TM ; Bolden, JE ; Fairfax, KA ; Robinson, AJ ; Biben, C ; Morgan, C ; Ramsay, K ; Ng, AP ; Kauppi, M ; Kruse, EA ; Sargeant, TJ ; Seidenman, N ; D'Amico, A ; D'Ombrain, MC ; Lucas, EC ; Koernig, S ; Morelli, AB ; Wilson, MJ ; Dower, SK ; Williams, B ; Heazlewood, SY ; Hu, Y ; Nilsson, SK ; Wu, L ; Smyth, GK ; Alexander, WS ; Hilton, DJ (CELL PRESS, 2016-09-13)
    Hematopoiesis is a multistage process involving the differentiation of stem and progenitor cells into distinct mature cell lineages. Here we present Haemopedia, an atlas of murine gene-expression data containing 54 hematopoietic cell types, covering all the mature lineages in hematopoiesis. We include rare cell populations such as eosinophils, mast cells, basophils, and megakaryocytes, and a broad collection of progenitor and stem cells. We show that lineage branching and maturation during hematopoiesis can be reconstructed using the expression patterns of small sets of genes. We also have identified genes with enriched expression in each of the mature blood cell lineages, many of which show conserved lineage-enriched expression in human hematopoiesis. We have created an online web portal called Haemosphere to make analyses of Haemopedia and other blood cell transcriptional datasets easier. This resource provides simple tools to interrogate gene-expression-based relationships between hematopoietic cell types and genes of interest.
  • Item
    Thumbnail Image
    Early Lineage Priming by Trisomy of Erg Leads to Myeloproliferation in a Down Syndrome Model
    Ng, AP ; Hu, Y ; Metcalf, D ; Hyland, CD ; Ierino, H ; Phipson, B ; Wu, D ; Baldwin, TM ; Kauppi, M ; Kiu, H ; Di Rago, L ; Hilton, DJ ; Smyth, GK ; Alexander, WS ; Grimes, HL (PUBLIC LIBRARY SCIENCE, 2015-05)
    Down syndrome (DS), with trisomy of chromosome 21 (HSA21), is the commonest human aneuploidy. Pre-leukemic myeloproliferative changes in DS foetal livers precede the acquisition of GATA1 mutations, transient myeloproliferative disorder (DS-TMD) and acute megakaryocytic leukemia (DS-AMKL). Trisomy of the Erg gene is required for myeloproliferation in the Ts(1716)65Dn DS mouse model. We demonstrate here that genetic changes specifically attributable to trisomy of Erg lead to lineage priming of primitive and early multipotential progenitor cells in Ts(1716)65Dn mice, excess megakaryocyte-erythroid progenitors, and malignant myeloproliferation. Gene expression changes dependent on trisomy of Erg in Ts(1716)65Dn multilineage progenitor cells were correlated with those associated with trisomy of HSA21 in human DS hematopoietic stem and primitive progenitor cells. These data suggest a role for ERG as a regulator of hematopoietic lineage potential, and that trisomy of ERG in the context of DS foetal liver hemopoiesis drives the pre-leukemic changes that predispose to subsequent DS-TMD and DS-AMKL.
  • Item
    Thumbnail Image
    Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice
    Ng, Ashley P. ; Loughran, Stephen J. ; METCALF, DONALD ; Hyland, Craig D. ; deGraaf, Carolyn A. ; Hu, Yifang ; Smyth, Gordon K. ; Hilton, Douglas J. ; Kile, Benjamin T. ; ALEXANDER, WARREN (American Society of Hematology, 2011)
    Hematopoietic stem cells (HSCs) are rare residents of the bone marrow responsible for the lifelong production of blood cells. Regulation of the balance between HSC self renewal and differentiation is central to hematopoiesis, allowing precisely regulated generation of mature blood cells at steady-state and expanded production at times of rapid need, as well as maintaining ongoing stem cell capacity. Erg, a member of the Ets family of transcription factors, is deregulated in cancers and while Erg is known to be required for regulation of adult HSCs, its precise role has not been defined. We show here that although heterozygosity for functional Erg is sufficient for adequate steady state HSC maintenance, Erg+/Mld2 mutant mice exhibit impaired HSC self-renewal following bone marrow transplantation or during recovery from myelotoxic stress. Moreover, while mice functionally compromised for either Erg or Mpl, the receptor for TPO, a key regulator of HSC quiescence, maintained sufficient HSC activity to sustain hematopoiesis, Mpl-/- Erg+/Mld2 compound mutant mice displayed exacerbated stem cell deficiencies and bone marrow failure. Thus, Erg is a critical regulator of adult HSCs, essential for maintaining self renewal at times of high HSC cycling.